Named on 5 rounds in the feed, most often at Series A.
Rounds from 2024-03-18 to 2025-09-25
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Thyme Care Thyme Care enhances the cancer journey with expert oncology navigation and an oncology care team, partnering to improve access, outcomes, and costs. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $97M | 2025-09-25 | [ PART ] |
Rad AI Radiology AI Platform for Reporting & Follow-Up | Series C Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $8M | 2025-05-20 | [ LEAD ] |
Spark Pediatrics Spark Pediatrics provides medical daycare services specifically designed for children with complex medical needs. | Funding round Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $15M | 2025-01-22 | [ LEAD ] |
Hippocratic AI Hippocratic AI offers generative AI solutions to improve communication and care delivery in healthcare settings, selling primarily to healthcare providers, payors, and pharmaceutical companies. | Series A ext. Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $17M | 2024-09-19 | [ PART ] |
Hippocratic AI Hippocratic AI offers generative AI solutions to improve communication and care delivery in healthcare settings, selling primarily to healthcare providers, payors, and pharmaceutical companies. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $53M | 2024-03-18 | [ PART ] |